Tremfya and Icotide are touted as key growth drivers in J&J’s strongly performing innovative medicines business.

Topline data were announced from a phase 3b trial evaluating the concomitant use of ixekizumab and tirzepatide in active PsA and obesity.

In a phase IIIb trial of adults with active psoriatic arthritis (PsA) and obesity or overweight, adding the GLP-1 drug ...

The global pharmaceutical industry will generate more than $1.2 trillion in sales in 2026, according to Statista. The oncology segment alone is expected to generate $232 billion in sales this year.

As of Tuesday, January 13, Enlivex Therapeutics Ltd.’s ENLV share price has dipped by 7.95%, which has investors questioning ...

Influenza vaccine uptake among children with JIA in Central and Eastern Europe increased from 18.6% before the COVID-19 pandemic to 24.1% in 2021.

There are reasons why the cold weather brings more cold and flu viruses. The good news is these remedies actually work.